
Owens & Minor OMI
$ 3.01
-0.17%
Quarterly report 2025-Q2
added 08-11-2025
Owens & Minor Gross Profit 2011-2025 | OMI
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Owens & Minor
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.22 B | 2.13 B | 1.83 B | 1.51 B | 1.28 B | 1.13 B | 1.37 B | 1.17 B | 1.19 B | 1.21 B | 1.17 B | 1.12 B | 925 M | 858 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.22 B | 858 M | 1.36 B |
Quarterly Gross Profit Owens & Minor
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 526 M | - | 560 M | 544 M | 536 M | - | 538 M | 519 M | 497 M | - | 513 M | 533 M | 373 M | - | 329 M | 400 M | 443 M | - | 344 M | 269 M | 269 M | - | 281 M | 287 M | 277 M | - | 353 M | 325 M | 325 M | - | 302 M | 274 M | 281 M | - | 296 M | 299 M | 297 M | - | 306 M | 298 M | 298 M | - | 292 M | 282 M | 281 M | - | 273 M | 273 M | 279 M | - | 228 M | 211 M | 214 M | - | 217 M | 216 M | 211 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 560 M | 211 M | 341 M |
Gross Profit of other stocks in the Medical distribution industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AmerisourceBergen Corporation
ABC
|
11.5 B | - | -0.23 % | $ 37.5 B | ||
|
Cardinal Health
CAH
|
8.17 B | $ 199.57 | 0.71 % | $ 48.1 B | ||
|
PPD, Inc.
PPD
|
1.8 B | - | 0.13 % | $ 16.6 B | ||
|
Henry Schein
HSIC
|
4.02 B | $ 77.33 | 1.03 % | $ 9.8 B | ||
|
McKesson Corporation
MCK
|
12.1 B | $ 822.75 | 1.11 % | $ 132 B | ||
|
Prestige Consumer Healthcare
PBH
|
634 M | $ 61.72 | 0.47 % | $ 3.07 B | ||
|
Patterson Companies
PDCO
|
1.37 B | - | -0.87 % | $ 3 B |